Bring Your Toughest AM Quality Problem To Formnext: Amsight Challenges Manufacturers To Rethink Production Quality
Mentionkit Publishes SourcetoMCP Case Study on Social Listening for B2B SaaS
Airia Named a Market Shaper as of October 2026 in the Gartner® Emerging Market Quadrant for AI FinOps Tools – Startup Vendors
Peec AI doubles revenue in six months to hit $20M ARR
warrantini puts warranty operations inside Claude, ChatGPT, and Microsoft Copilot
-Data to be shared at the American Association of Immunologists (AAI) Annual Meeting -Results highlight…
Urges Shareholders to Vote “FOR” Athira’s Highly Qualified, Independent Director Nominees – Joseph Edelman, John…
LEXINGTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”)…
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical…
Conference Call and Live Audio Webcast Scheduled for Thursday, May 12, 2022, 5:00 p.m. ET…
The investigational prescription digital therapeutic uses a combination of sensors, software, and music based on…
Study will use delta-9 dominant THCV manufactured by InMed’s subsidiary BayMedica Assesses key health outcomes…
Q1 2022 TYMLOS® product net revenue of $43 million vs. $45 million in Q1 2021°…
Cytokine-Based Fusion Proteins to Activate and Expand Memory-Like NK Cells Without Using Feeder CellsSufficient for Off-the-Shelf…
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a…
–Completed sale to Sentynl Therapeutics of BridgeBio’s NULIBRY™ (Fosdenopterin) for Injection –Updated strategic collaboration with…
TORONTO, May 05, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCD) will announce its…
– Phase 1 trial of SEL-302 remains on track to initiate in the second half…
Lead clinical-stage oral progesterone receptor (PR) antagonist ONA-XR demonstrates monotherapy clinical activity in advanced granulosa…
Reaffirms milestone timing for Phase 2 clinical trial of AVTX-002 in non-eosinophilic asthma (NEA) and…
Key milestones across our chronic hepatitis B virus (cHBV) and pan-coronavirus programs remain on track Well…
Earned a $2 million milestone from Rezolute as it dosed the final patient in a…
GAITHERSBURG, Md., May 05, 2022 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
Sorbitol correlates with disease severity in patients with SORD Deficiency AT-007 treatment substantially reduced sorbitol…
Presented updated interim data from ongoing Phase 1 study in patients with transthyretin (ATTR) amyloidosis…